Biggest Catalyst from today's News:- "we await the forthcoming results from our pivotal Phase 3 OnTarget trial of crofelemer for cancer therapy-related diarrhea, an indication we also refer to as chemotherapy-induced overactive bowel (CIOB)"
It will released any day now and once released it will be already up by 200% or more in the pre-market trading.
So better get in now!!! IF YOU WANT $$$$$$$$$$$$$$$
News 
Market Data 
Discover 
